Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Denis Y. Logunov, Inna V. Dolzhikova, Dmitry V. Shcheblyakov, Amir I. Tukhvatulin, Olga V. Zubkova, Alina S. Dzharullaeva, Anna V. Kovyrshina, Nadezhda L. Lubenets, Daria M. Grousova, Alina S. Erokhova, А Г Ботиков, Fatima M. Izhaeva, Olga Popova, Tatiana A Ozharovskaya, I. B. Esmagambetov, I. A. FAVORSKAYA, Denis I. Zrelkin, Daria V. Voronina, Dmitry N. Shcherbinin, А. С. Семихин, Yana V. Simakova, Elizaveta A. Tokarskaya, Д.А. Егорова, М. М. Шмаров, Н. А. Никитенко, Vladimir А. Gushchin, Е. А. Smolyarchuk, S. К. Zyryanov, Sergei V. Borisevich, Boris S. Naroditsky, Gintsburg Al